March 6, 2015
Prof. Kojiro Ueki Japan’s sodium glucose co-transporter-2 (SGLT-2) inhibitor market saw the debut of seven products of six compounds in a span of just 10 months. These drugs reduce blood sugar levels by excreting glucose in urine, a novel mechanism...read more